Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: J Urol. 2012 Nov 20;189(1):238–242. doi: 10.1016/j.juro.2012.08.089

Table 2.

Comparison between men undergoing ORRP who have ever used ICI versus those who have never used ICI.

VARIABLE Users (n=140) Non-Users (n=228) p-value

Age 58.7 ± 0.523 59.0 ± 0.409 .671

Race African-American: 5 African-American: 5 .094
Asian: 0 Asian: 6
Caucasian: 133 Caucasian: 214
Hispanic: 2 Hispanic: 0
Other: 0 Other: 1
No Response: 0 No Response: 2

Marital Status Divorced: 7 Divorced: 8 .975
Married: 123 Married: 206
Separated: 1 Separated: 2
Single: 6 Single: 8
Widowed: 2 Widowed: 3
No Response: 1 No Response: 1

BMI 26.8 ± 0.309 26.9 ± 0.255 .666

PSA 5.79 ± 0.299 6.40 ± 0.382 .265

Pathologic Gleason Score 2–6: 83 2–6: 141 .199
7: 51 7: 84
8–10: 6 8–10: 3

Pathologic Stage 0–2: 115 0–2: 194 .455
3–4: 25 3–4: 34

Nerve Sparing Status None: 5 None: 6 .842
Unilateral: 20 Unilateral: 30
Bilateral: 115 Bilateral: 190

Length of Hosp Stay 2.08 ± 0.0497 2.07 ± 0.0489 .957

EBL 743.1 ± 27.8 784.0 ± 25.8 .301

Pre-operative UCLA-PCI Score 74.9 ± 1.59 65.6 ± 1.57 .00005*

Pre-operative minus 3 Month UCLA-PCI Score 53.5 ± 1.72 44.5 ± 1.60 .0002*

Pre-operative minus 2 Year UCLA-PCI Score 33.9 ± 2.19 26.1 ± 1.58 .003*

Pre-operative minus 8 Year UCLA-PCI Score 30.7 ± 2.84 25.9 ± 1.68 .149
*

significant